gene therapy

An ALS compound that's ready for biotech development is described in this Oct. 5, 2009, Webcast

Posted on Sunday, October 18, 2009 - 13:54, By: ALSN Staff
A Webcast is now available of the fourth annual research symposium held as part of the ALS TDI Leadership Summit 2009 on Oct. 5. The symposium was conducted at the MDA-supported ALS Therapy Development Institute in Cambridge, Mass.

An ALS Therapy Development Institute Webcast summarizes research progress as of July 2009

Posted on Wednesday, July 29, 2009 - 10:38, By: Amy Madsen
On July 16, 2009, the MDA-supported ALS Therapy Development Institute (ALS TDI) gave its quarterly research update in a Webcast that's now archived on the Institute's site and accessible to all who register. (See Research Update Q209.)

MMD, FSHD, OPMD, and some forms of EDMD and ALS, might benefit from new strategy

Posted on Saturday, April 18, 2009 - 14:33, By: Margaret Wahl
A new gene therapy approach to "silencing" disease-causing genetic information has been developed by researchers at Rutgers University in Piscataway, N.J., and Integrated DNA Technologies in Coralville, Ia.
Posted on Sunday, March 1, 2009 - 13:24, By: ALSN Staff
ALS TDI and Asklepios collaborating on gene therapy development
Posted on Thursday, January 1, 2009 - 09:16, By: Amy Madsen
Genes encased in adeno-associated virus (AAV) delivery vehicles are injected into muscle. From there they can travel through the nerve fiber to the nervous system.

Getting past barriers

Posted on Tuesday, July 1, 2008 - 10:55, By: Margaret Wahl
Gene therapy experts discuss targeting ALS-affected cells The 11th annual meeting of the American Society of Gene Therapy (ASGT) took place in Boston May 28-June 1. Among the dozens of sessions was an MDA-sponsored program on gene therapy for neurodegeneration.
Posted on Monday, January 1, 2007 - 09:16, By: Margaret Wahl
Editor’s Note: The 17th International Symposium on ALS/MND (Amyotrophic Lateral Sclerosis/Motor Neurone Disease), held in Yokohama, Japan, Nov. 30 through Dec. 2, showcased important research findings, many of which involved MDA research grantees and clinicians. News items from the meeting are...